S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:APPN

Appian (APPN) Stock Price, News & Analysis

$34.55
-0.31 (-0.89%)
(As of 04:00 PM ET)
Today's Range
$34.03
$35.20
50-Day Range
$31.68
$41.12
52-Week Range
$30.87
$54.26
Volume
495,986 shs
Average Volume
497,429 shs
Market Capitalization
$2.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.86

Appian MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
41.8% Upside
$48.86 Price Target
Short Interest
Bearish
3.00% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.82
Upright™ Environmental Score
News Sentiment
0.32mentions of Appian in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$12.98 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.98) to ($0.27) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.23 out of 5 stars

Computer And Technology Sector

132nd out of 582 stocks

Prepackaged Software Industry

35th out of 198 stocks

APPN stock logo

About Appian Stock (NASDAQ:APPN)

Appian Corporation, a software company that provides low-code design platform in the United States, Mexico, Portugal, and internationally. The company's platform offers artificial intelligence, process automation, data fabric, and process mining. It provides The Appian Platform, an integrated automation platform that enables organizations to design, automate, and optimize mission-critical business processes. The company also offers professional and customer support services. It serves to financial services, government, life sciences, insurance, manufacturing, energy, healthcare, telecommunications, and transportation industries. Appian Corporation was incorporated in 1999 and is headquartered in McLean, Virginia.

APPN Stock Price History

APPN Stock News Headlines

Appian: No Recovery Yet
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Appian (NASDAQ:APPN) Given New $36.00 Price Target at Barclays
Wake Up to Wealth: 7 Sleeper Stocks Ready to Roar
Cracking The Code: Understanding Analyst Reviews For Appian
APPN Apr 2024 30.000 put
APPN Apr 2024 40.000 call
The Analyst Verdict: Appian In The Eyes Of 4 Experts
Appian to Participate in Upcoming Investor Conferences
See More Headlines
Receive APPN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Appian and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
4/19/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:APPN
Fax
N/A
Employees
2,243
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$48.86
High Stock Price Target
$55.00
Low Stock Price Target
$36.00
Potential Upside/Downside
+41.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

Net Income
$-111,440,000.00
Pretax Margin
-19.85%

Debt

Sales & Book Value

Annual Sales
$545.36 million
Book Value
$0.71 per share

Miscellaneous

Free Float
41,398,000
Market Cap
$2.53 billion
Optionable
Optionable
Beta
1.46
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

APPN Stock Analysis - Frequently Asked Questions

Should I buy or sell Appian stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Appian in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" APPN shares.
View APPN analyst ratings
or view top-rated stocks.

What is Appian's stock price target for 2024?

8 Wall Street research analysts have issued 12 month price objectives for Appian's stock. Their APPN share price targets range from $36.00 to $55.00. On average, they expect the company's stock price to reach $48.86 in the next twelve months. This suggests a possible upside of 41.8% from the stock's current price.
View analysts price targets for APPN
or view top-rated stocks among Wall Street analysts.

How have APPN shares performed in 2024?

Appian's stock was trading at $37.66 at the beginning of the year. Since then, APPN shares have decreased by 8.5% and is now trading at $34.46.
View the best growth stocks for 2024 here
.

Are investors shorting Appian?

Appian saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,200,000 shares, an increase of 8.4% from the March 15th total of 2,030,000 shares. Based on an average daily volume of 480,300 shares, the days-to-cover ratio is presently 4.6 days.
View Appian's Short Interest
.

When is Appian's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our APPN earnings forecast
.

How were Appian's earnings last quarter?

Appian Co. (NASDAQ:APPN) released its earnings results on Thursday, February, 15th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.40) by $0.33. The company earned $145.32 million during the quarter, compared to the consensus estimate of $140.41 million. Appian had a negative trailing twelve-month return on equity of 127.40% and a negative net margin of 20.43%.

What guidance has Appian issued on next quarter's earnings?

Appian issued an update on its first quarter 2024 earnings guidance on Saturday, April, 6th. The company provided EPS guidance of -0.210--0.160 for the period, compared to the consensus EPS estimate of -0.180. The company issued revenue guidance of $148.0 million-$150.0 million, compared to the consensus revenue estimate of $149.5 million.

What is Matt Calkins' approval rating as Appian's CEO?

281 employees have rated Appian Chief Executive Officer Matt Calkins on Glassdoor.com. Matt Calkins has an approval rating of 82% among the company's employees. 88.0% of employees surveyed would recommend working at Appian to a friend.

What other stocks do shareholders of Appian own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Appian investors own include NVIDIA (NVDA), Trade Desk (TTD), Okta (OKTA), Shopify (SHOP), Block (SQ), Twilio (TWLO), Zoom Video Communications (ZM), Tesla (TSLA), PayPal (PYPL) and CrowdStrike (CRWD).

When did Appian IPO?

Appian (APPN) raised $76 million in an IPO on Thursday, May 25th 2017. The company issued 6,300,000 shares at a price of $11.00-$13.00 per share. Morgan Stanley, Goldman, Sachs and Barclays acted as the underwriters for the IPO and Pacific Crest Securities (a division of KeyBanc Capital Markets), Canaccord Genuity and Cowen and Company were co-managers.

Who are Appian's major shareholders?

Appian's stock is owned by a variety of institutional and retail investors. Top institutional investors include Los Angeles Capital Management LLC (0.03%). Insiders that own company stock include Abdiel Capital Advisors, Lp, Abdiel Capital Management, Llc, Albert GW Biddle III, Christopher M Jones, Christopher Winters, Eric Calvin Cross, Mark Matheos, Mark Steven Lynch, Michael G Devine, Pavel Zamudio-Ramirez and Robert Charles Kramer.
View institutional ownership trends
.

How do I buy shares of Appian?

Shares of APPN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:APPN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners